Are Gallstones a Side Effect of Ozempic? Understanding the Risks

Last reviewed: June 9, 2026

Last updated: June 9, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

GLP-1 receptor agonists like semaglutide have transformed weight loss treatment for millions of people, but rapid weight reduction—a key benefit—also carries metabolic side effects worth understanding. Gallstone formation, medically called cholelithiasis, occurs in roughly 1–2% of GLP-1 users, primarily because fast fat mobilization from the liver increases cholesterol concentration in bile. PlexusDx helps you navigate these risks with personalized therapy and ongoing clinical monitoring.

How Rapid Weight Loss Increases Gallstone Risk

The gallbladder stores and concentrates bile, a digestive fluid made partly of cholesterol. When you lose weight quickly—especially more than 1–2 pounds per week—your liver releases stored fat into the bloodstream for energy. This flood of fat increases the cholesterol saturation in bile, creating an environment where cholesterol crystals cluster together and form stones. Studies show that intentional weight loss lasting 6–12 months raises gallstone incidence compared to gradual weight change over years.

GLP-1 medications accelerate this process by suppressing appetite and slowing gastric emptying, which means you consume fewer calories and your body burns stored fat faster. The risk is not unique to compounded semaglutide or tirzepatide—it applies to all GLP-1 therapy—but understanding your individual metabolic profile helps PlexusDx optimize your dose escalation and monitoring timeline to minimize complications.

Who Is Most at Risk for Gallstone Formation

Certain patient characteristics predict higher gallstone risk during weight loss therapy. People with a family history of gallbladder disease, those who are female, those over 40 years old, those who are obese at baseline, and those with metabolic syndrome or insulin resistance face elevated odds. Additionally, individuals with pre-existing fatty liver disease or low HDL cholesterol show accelerated bile changes during rapid fat mobilization. The Precision Peptide Genetic Test offered by PlexusDx evaluates variants in metabolic pathways—including FTO rs9939609 and MC4R rs17782313—that influence how your body processes fat and responds to weight loss, helping identify genetic predispositions before treatment begins.

Even without genetic testing, discussing your personal and family medical history with your PlexusDx clinical team during your initial consultation is essential. Age, sex, baseline BMI, and existing liver or gallbladder ultrasound findings all shape your individualized risk profile and treatment plan.

Monitoring and Prevention Strategies During GLP-1 Treatment

Preventing gallstones while taking semaglutide or tirzepatide involves three practical steps: gradual dose escalation, adequate hydration and dietary fat intake, and scheduled ultrasound screening if you have risk factors. PlexusDx designs dose schedules that balance therapeutic weight loss against metabolic stress—your dose may need to go up, but your price won't, keeping treatment affordable as your therapy advances. Most GLP-1 protocols start low and titrate over 4–8 weeks, which slows fat mobilization compared to rapid dosing.

Nutritional support matters too. Consuming 25–30 grams of fat daily—rather than ultra-low-fat diets—keeps the gallbladder contracting regularly and prevents bile stasis. Drinking 8–10 glasses of water daily supports hepatic function and reduces bile viscosity. For patients at high risk, a baseline abdominal ultrasound before starting treatment and a repeat study at 6–12 months provides early detection if stones form, allowing intervention before pain or complications occur. Your PlexusDx clinical team coordinates these screening recommendations based on your individual risk assessment.

PlexusDx Personalized Approaches to Minimize Gallstone Complications

PlexusDx offers multiple formulations and protocols to optimize safety and efficacy. Compounded Semaglutide Injection starts at $149 per month with flexible dosing to match your body's metabolism. Oral Semaglutide ($249/mo) or Oral Tirzepatide ($279/mo) may suit patients who prefer needle-free administration. For those wanting dual-pathway therapy, GLP-Squared Injection (combining semaglutide and tirzepatide, starting at $249/mo) delivers potent weight loss with closer medical oversight. The Microdose GLP-1 Protocol ($129/mo) provides a gentler entry point for GLP-1-naïve patients or those with borderline risk factors, potentially reducing acute metabolic stress and gallstone formation.

The Precision Peptide Genetic Test ($99 add-on after your first month) maps 14 metabolic pathways across 49 peptides, revealing how variants like GIPR rs1800437 and GLP1R rs6923761 shape your response to therapy. This insight lets PlexusDx clinicians fine-tune your formulation choice, dose timing, and monitoring intervals before problems arise. All medications come from licensed 503A compounding pharmacies, require no insurance, carry no membership fee, and are HSA/FSA eligible—making personalized, safe weight loss accessible across all 50 states.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Do all GLP-1 medications carry the same gallstone risk?

Yes, gallstone formation is a class effect linked to rapid weight loss, not to any single GLP-1 drug. Semaglutide, tirzepatide, and other GLP-1 agonists all increase risk proportional to the speed of fat loss. PlexusDx manages this risk through customized dose escalation and monitoring regardless of which formulation you choose.

What symptoms suggest gallstones are forming?

Biliary colic typically presents as sudden, severe pain in the right upper abdomen, often radiating to the back or right shoulder, and may last 30 minutes to several hours. Nausea, vomiting, and pain after fatty meals are common. If you experience these symptoms during GLP-1 therapy, contact your PlexusDx provider immediately—early ultrasound can confirm diagnosis and guide next steps.

How much does PlexusDx Semaglutide Injection cost, and does price change if my dose increases?

Compounded Semaglutide Injection starts at $149 per month with no flat per-compound pricing increases—your dose may need to go up, your price won't. PlexusDx serves all 50 states without insurance requirements, membership fees, or hidden charges, and treatments are HSA/FSA eligible.

Can I prevent gallstones while taking semaglutide or tirzepatide?

Prevention involves gradual dose titration, maintaining 25–30 grams of daily dietary fat, staying well-hydrated, and screening with abdominal ultrasound if you have risk factors like age over 40, female sex, or family history. PlexusDx coordinates these strategies as part of your personalized treatment plan to minimize complications.

How does the Precision Peptide Genetic Test help reduce gallstone risk?

PlexusDx's Precision Peptide Genetic Test ($99 after your first month) identifies variants in metabolic pathways—including FTO rs9939609 and MC4R rs17782313—that predict how quickly you'll lose fat and mobilize cholesterol. This genetic insight allows your clinician to adjust your dose schedule and formulation choice upfront, reducing acute metabolic stress and gallstone formation before they occur.

Related Reading

• Ozempic Side Effects
• What Genetic Factors Affect Ptsd Severity How Can Understanding Help Manage Risks
• Lifemd Ozempic
• Eden Ozempic

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.